Differences were considered significant and extremely significant at p < 0.05 and p < 0.01, respectively.
Excerpts
Although pointing in the same direction, the difference in this outcome between CS+ cues and CSA cues just failed to reach significance ( Z = −1.95, P = 0.05).
The addition of 1 and 3 g/kg b.wt of JDL extract could upregulate the level of NQO1 at 6 and 12 h of heat stress, and both showed highly significant differences, whereas the level of HO-1 had only shown a difference at 6 h of heat stress, with 1 g/kg b.wt ( P < 0.05) and 3 g/kg b.wt ( P < 0.01).
Breaking the interaction down, there was a marginally significant effect for inhibition control ability in A-2 condition, χ 2 = 3.74, df = 1, p = 0.05, suggesting better inhibition control ability indicates faster response in the A-2 condition.
Studies have shown that the NHPT discriminates manual dexterity in MS patients from healthy controls at a highly significant level ( p < 0.05). 24 , 25 Based on cross-sectional work, a number of research groups have recommended cut scores to identify levels of impairment on the NHPT ( Table 2 ).
The number of IFN-γ-secreting cells was highly significant in all monkeys except one, including the control animals ( p < 0.05, p < 0.005, p < 0.0001).
We used linear trends to categorize sites into three distinct groups based on their changes on EQR and CWM‐ DCM over time: (1) recovering sites with a positive trend (positive slope and p < 0.05), (2) stable sites with no trend ( p > 0.05), and (3) degrading sites with a negative trend (negative slope and p < 0.05).
Only a near-significant effect for baseline beta was found, showing a slight increase over the sessions with exclusion of comorbid disorders, F (1, 796.367) = 3.862, p = 0.050, b = 0.00095, 95% CI = [0.000001 to 0.001903].
showed a trendp>0.05
No significant difference in mortality was observed across RACHS-1 categories, although patients in high-risk categories (RACHS ≥4) showed a trend toward increased mortality (72% vs . 59%, p>0.05).
Lastly, a nearly significant difference (p=0.05) was seen in the reports of modest weight gain: two (3%) trazodone users, five (9%) doxepin users, and none of the melatonin users, as illustrated in Figure 1 .
The Cochran-Armitage trend test showed an overall increasing trend in the prevalence of DPN, DPVD, hypertension, DN, CI, lithiasis, DR, DF, and anemia with increasing age ( P < 0.05), while there was a decreasing trend in the prevalence of FL ( P < 0.05).
Both cell types showed a markedly significant decrease ( p < 0.05) in the basal OCR after a 24 h combination treatment compared with the untreated control, and not surprisingly, we also observed a significant decrease ( p < 0.05) in the ECAR (extracellular acidic ratio; an indicator of glycolysis flux) following a combination treatment in both cell types ( supporting information, Figure S9 ).
The findings for ‘own promotion’ indicated that detailing produced a highly significant positive impact on new prescriptions for Lipitor and Crestor (p<0.05), while results were not significant for Vytorin. ‘Competitive’ detailing had a significant negative impact on new prescription for Vytorin (p<0.05) whereas results were not significant for the other two brands.
showed a trendp < 0.05
In the other two intestinal segments, this correlation is less significant, as IGF-I in the duodenum showed a trend of positive correlation with IL-1β (0.01 ≤ p < 0.05) and a potential positive correlation with SIgA in the ileum ( p < 0.10).
In the multivariate analysis, there was a borderline significant risk reduction of 20% with increased activity (aHR moderate 0.80, 95% CI 0.63-1.00, p=0.05 and aHR high 0.80, 95% CI 0.64-1.01, p=0.06).
However, the change was marginally significant ( p = 0.05).
Asterisks: highly significant alteration in indicated pairwise comparisons, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 and **** p ≤ 0.0001, ns: no significant difference. 3.
a trend toward significanceP <0.05
There was a trend toward significance ( P <0.05) with systolic BP, pulse pressure, and total arterial compliance (Table 3 ).
As shown in Figure 6 A, the O 2.- production rates of all the treatments presented an increasing trend, and the O 2.- production rates of the treatment group M5 were all significantly lower than that of the control ( p < 0.05).
The interpretation of the tests comparing averages, Anova, Student, Wilcoxon, Kruskal-Wallis: P < 0,05, the difference is significant (s) P < 0,01, the difference is highly significant (hs) P < 0,05, the difference is insignificant (ns) The interpretation of P values at dependence tests of factors: P < 0,05, the dependence between the two factors is significant (s) P < 0,01, the dependance is highly significant (hs) P < 0,001, the dependance is very high significant (vhs) P > 0,05, the dependance is insignificant (ns) Results The progression of sacroiliitis to degree 3-4 unilaterally or 2 bilaterally after aproximaly 2 years after diagnosing reactive arthritis in the case of the first batch of patients allowed setting the diagnosis of ankylosing spondylitis.
For learning experience, there was almost significant correlation between all sub-indicators ( r = 0.792–0.907, P < 0.05).
Body Composition and Cardiometabolic Health NC members had significantly higher percent body fat ( P < 0.001) and marginally significant higher diastolic blood pressure ( P = 0.05), but lower waist-to-hip ratio (0.87 vs 0.89, P = 0.04) than CC (Table 2 ).
Only lymph node status had a marginally significant effect on DFS (total number of cases: 1528; Z = 1.94; p = 0.05): positive lymph node status significantly worsened the prognosis (HR > 1) by reducing DFS.
Ever-use of systemic HC was associated with earlier FS (39.3 vs 43.4 years), but this was marginally significant (linear regression, estimate = 2.1, p = 0.05; figure ).
Vascular and systemic inflammation There was a borderline significant positive correlation between abdominal aortic TBR with both WCC and neutrophils ( r = + 0.18, p = 0.05 and r = + 0.17, p = 0.06) in the whole cohort only.